Natalie Wolkow is an Ophthalmology physician affiliated with Massachusetts Eye and Ear Infirmary. OpenAlex indexes 121 publications with 1,258 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
243 Charles St
Boston, MA 021143002
Telephone
617-573-3319Registry record last updated 21 Jul 2022.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BIOTISSUE HOLDINGS INC.Program year20251 payment
- Amgen Inc.Program year20241 payment
- Horizon Therapeutics plcProgram year20233 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
86%Macrolide71.1%Erythromycin100%Part D≥63 patientsTetracycline-class Drug14.9%Doxycycline Monohydrate100%Part D<11 patientsSensory organs
14%Aminoglycoside Antibacterial14%Neomycin-Polymyxin-Dexameth100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Immunotherapy for Advanced Conjunctival Squamous Cell Carcinoma: Treatment Failures
Ophthalmic Plastic and Reconstructive Surgery
2025 - Longitudinal Glycemic Outcomes in Patients With Thyroid Eye Disease Treated With Teprotumumab
Ophthalmic Plastic and Reconstructive Surgery
2025 - Percent reduction in proptosis after teprotumumab treatment for thyroid eye disease
British Journal of Ophthalmology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
John Kempen, MD
Massachusetts Eye and Ear Infirmary
Neil Bhattacharyya, MD, FACS
Massachusetts Eye and Ear Infirmary
Demetrios Vavvas, MD, PhD
Massachusetts Eye and Ear Infirmary
Evangelos Gragoudas, MD
Massachusetts Eye and Ear Infirmary
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”